Canada Life’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $188M | Buy |
6,657,890
+6,195
| +0.1% | +$165K | 0.34% | 55 |
|
|
2025
Q4 | $166M | Sell |
6,651,695
-1,690,687
| -20% | -$42.6M | 0.29% | 64 |
|
|
2025
Q3 | $199M | Sell |
8,342,382
-216,151
| -3% | -$5.34M | 0.28% | 61 |
|
|
2025
Q2 | $208M | Buy |
8,558,533
+1,404,763
| +20% | +$32.8M | 0.33% | 58 |
|
|
2025
Q1 | $182M | Buy |
7,153,770
+474,829
| +7% | +$12.4M | 0.32% | 60 |
|
|
2024
Q4 | $177M | Buy |
6,678,941
+261,847
| +4% | +$7.1M | 0.31% | 54 |
|
|
2024
Q3 | $186M | Buy |
6,417,094
+182,099
| +3% | +$5.31M | 0.32% | 52 |
|
|
2024
Q2 | $175M | Sell |
6,234,995
-565,753
| -8% | -$15.6M | 0.33% | 50 |
|
|
2024
Q1 | $189M | Buy |
6,800,748
+179,559
| +3% | +$4.98M | 0.38% | 49 |
|
|
2023
Q4 | $190M | Buy |
6,621,189
+171,142
| +3% | +$5.17M | 0.42% | 44 |
|
|
2023
Q3 | $214M | Buy |
6,450,047
+220,728
| +4% | +$7.81M | 0.51% | 34 |
|
|
2023
Q2 | $230M | Buy |
6,229,319
+451,990
| +8% | +$17.6M | 0.54% | 29 |
|
|
2023
Q1 | $236M | Buy |
5,777,329
+10,761
| +0.2% | +$465K | 0.59% | 26 |
|
|
2022
Q4 | $297M | Buy |
5,766,568
+80,595
| +1% | +$3.86M | 0.78% | 18 |
|
|
2022
Q3 | $249M | Sell |
5,685,973
-74,103
| -1% | -$3.6M | 0.71% | 18 |
|
|
2022
Q2 | $303M | Sell |
5,760,076
-642,907
| -10% | -$32.8M | 0.8% | 17 |
|
|
2022
Q1 | $348M | Sell |
6,402,983
-245,431
| -4% | -$12.7M | 0.73% | 18 |
|
|
2021
Q4 | $391M | Buy |
6,648,414
+459,490
| +7% | +$22.8M | 0.81% | 18 |
|
|
2021
Q3 | $268M | Sell |
6,188,924
-267,544
| -4% | -$11.9M | 0.62% | 27 |
|
|
2021
Q2 | $253M | Buy |
6,456,468
+281,080
| +5% | +$10.9M | 0.58% | 33 |
|
|
2021
Q1 | $222M | Sell |
6,175,388
-70,145
| -1% | -$2.49M | 0.54% | 36 |
|
|
2020
Q4 | $229M | Buy |
6,245,533
+25,561
| +0.4% | +$938K | 0.43% | 54 |
|
|
2020
Q3 | $217M | Sell |
6,219,972
-47,499
| -0.8% | -$1.67M | 0.47% | 48 |
|
|
2020
Q2 | $194M | Buy |
6,267,471
+77,871
| +1% | +$2.65M | 0.44% | 52 |
|
|
2020
Q1 | $193M | Sell |
6,189,600
-810
| -0% | -$27.6K | 0.52% | 44 |
|
|
2019
Q4 | $228M | Sell |
6,190,410
-811,469
| -12% | -$28.9M | 0.5% | 46 |
|
|
2019
Q3 | $239M | Buy |
7,001,879
+40,353
| +0.6% | +$1.47M | 0.57% | 39 |
|
|
2019
Q2 | $287M | Sell |
6,961,526
-197,259
| -3% | -$7.83M | 0.65% | 29 |
|
|
2019
Q1 | $288M | Buy |
7,158,785
+382,098
| +6% | +$15.3M | 0.76% | 26 |
|
|
2018
Q4 | $271M | Sell |
6,776,687
-1,598,029
| -19% | -$66.3M | 0.78% | 22 |
|
|
2018
Q3 | $351M | Sell |
8,374,716
-815,474
| -9% | -$31.4M | 0.83% | 19 |
|
|
2018
Q2 | $317M | Buy |
9,190,190
+425,662
| +5% | +$14.5M | 0.74% | 23 |
|
|
2018
Q1 | $295M | Buy |
8,764,528
+764,993
| +10% | +$26.3M | 0.71% | 26 |
|
|
2017
Q4 | $275M | Buy |
7,999,535
+203,315
| +3% | +$6.93M | 0.65% | 31 |
|
|
2017
Q3 | $263M | Buy |
7,796,220
+285,945
| +4% | +$9.19M | 0.65% | 29 |
|
|
2017
Q2 | $239M | Sell |
7,510,275
-215,020
| -3% | -$6.78M | 0.64% | 29 |
|
|
2017
Q1 | $251M | Sell |
7,725,295
-33,934
| -0.4% | -$1.07M | 0.68% | 29 |
|
|
2016
Q4 | $240M | Buy |
7,759,229
+403,390
| +5% | +$12.3M | 0.68% | 30 |
|
|
2016
Q3 | $236M | Buy |
7,355,839
+151,376
| +2% | +$5.06M | 0.69% | 29 |
|
|
2016
Q2 | $240M | Buy |
7,204,463
+1,434,444
| +25% | +$45.8M | 0.72% | 23 |
|
|
2016
Q1 | $162M | Sell |
5,770,019
-364,782
| -6% | -$10.4M | 0.59% | 35 |
|
|
2015
Q4 | $188M | Sell |
6,134,801
-1,693,694
| -22% | -$53.3M | 0.72% | 23 |
|
|
2015
Q3 | $234M | Buy |
7,828,495
+427,606
| +6% | +$13.7M | 0.92% | 19 |
|
|
2015
Q2 | $235M | Sell |
7,400,889
-458,633
| -6% | -$14.9M | 0.81% | 21 |
|
|
2015
Q1 | $259M | Buy |
7,859,522
+461,574
| +6% | +$14.7M | 0.88% | 17 |
|
|
2014
Q4 | $218M | Buy |
7,397,948
+231,607
| +3% | +$6.64M | 0.72% | 23 |
|
|
2014
Q3 | $202M | Sell |
7,166,341
-76,825
| -1% | -$2.16M | 0.68% | 28 |
|
|
2014
Q2 | $203M | Buy |
7,243,166
+362,843
| +5% | +$10.3M | 0.67% | 30 |
|
|
2014
Q1 | $208M | Buy |
6,880,323
+938,130
| +16% | +$28M | 0.73% | 22 |
|
|
2013
Q4 | $174M | Buy |
5,942,193
+154,764
| +3% | +$4.5M | 0.62% | 31 |
|
|
2013
Q3 | $157M | Buy |
5,787,429
+4,597,852
| +387% | +$125M | 0.62% | 32 |
|
|
2013
Q2 | $31.7M | Buy |
+1,189,577
| New | +$32.9M | 0.21% | 96 |
|
Other funds holding PFE
VCM
VPM
Canada Life's PFE Position: Q1 2026 in Review
Canada Life increased its Pfizer (PFE) stake by 0.09% in Q1 2026, buying an estimated $165K and bringing the position to 6,657,890 shares worth $188M. The position accounts for 0.34% of the portfolio, ranked #55.
Canada Life first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $391M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Canada Life held 6,657,890 shares of Pfizer worth $188M as of Q1 2026.
- Canada Life bought 6,195 Pfizer shares in Q1 2026, an estimated $165K.
- Pfizer made up 0.34% of Canada Life's portfolio in Q1 2026, its #55 holding.
- Canada Life first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Canada Life's Pfizer position peaked at $391M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.